IIL inks pact with INTA, Littoral Biologics of Argentina

Indian Immunologicals Limited (IIL) today said it has signed a MoU with Argentina's Instituto Nacional de Tecnologia Agropecuaria (INTA) and Littoral Biologics of Argentina for transfer of technology for Bovine Parasitic vaccines in India.
According to a media release issued by IIL, introduction of vaccines against haemoprotozoan infections transmitted by ticks such as Babesiosis and Anaplasmosis will prevent loss in productivity in cattle and immensely benefit dairy farmers.
INTA is Argentinian federal agency in charge of the generation, adaptation and diffusion of technologies.
"Economic losses due to Babesisosis alone in India are estimated to be about USD 57.2 million," said K Anand Kumar, Managing Director, IIL.

"IIL is only vaccine manufacturer in India which is capable of producing effective parasitic vaccines for animals with vast experience in producing vaccine against haemoprotozoan Theileria annulata, since three decades.
"IIL recently introduced vaccine against Porcine Cysticercosis, a parasitic vaccine for pigs. This agreement with the Argentinean collaborators will go a long way in uplifting productivity among dairy farmers in India," added Kumar.
IIL is set to address this unmet need to control haemoprotozoan diseases transmitted by ticks in India and prevent loss of productivity in cattle, said the release.